Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/1998
05/06/1998EP0839912A1 Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
05/06/1998EP0839911A1 Method for identifying attenuated chickenpox virus oka strain or strain originating therein and acceptable as attenuated chickenpox vaccine virus
05/06/1998EP0839910A2 Spo-rel, a Staphylococcus relA/spot homologue
05/06/1998EP0839908A2 A novel human ETS family member, ELF3
05/06/1998EP0839831A2 Single chain gonadotropin
05/06/1998EP0839536A1 Methods and compositions for promoting immunopotentiation
05/06/1998EP0839199A1 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses
05/06/1998EP0839197A2 MODIFIED HUMAN CHORIONIC ($g(b)-hCG) PROTEINS AND THEIR MEDICAL USE
05/06/1998EP0839195A1 Nucleotide and peptide sequences for treating myasthenia
05/06/1998EP0839191A1 Autoreactive peptides from human glutamic acid-decarboxylase (gad)
05/06/1998EP0839183A1 Immortalized epithelial tumor cell
05/06/1998EP0839054A1 Tumor- or cell-specific herpes simplex virus replication
05/06/1998EP0839050A1 Method of enhancing cell mediated immune responses
05/06/1998EP0839044A1 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response
05/06/1998EP0673418B1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
05/06/1998EP0591452B1 Multiple emulsions and methods of preparation
05/06/1998CN1181020A Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation mthod therefor and pharmaceutical compositions containing same
05/06/1998CN1180711A Thioether conjugates
05/05/1998US5747659 Increased egg lay; fertility agents
05/05/1998US5747654 Recombinant disulfide-stabilized polypeptide fragments having binding specificity
05/05/1998US5747653 Vaccination against infection caused by neisseria and purified with protein antigens complexes
05/05/1998US5747646 Polyethylene-protein conjugates
05/05/1998US5747643 Antibodies and peptides for antitumor agents
05/05/1998US5747641 Tat-derived transport polypeptide conjugates
05/05/1998US5747532 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
05/05/1998US5747526 Anti-HIV /Aids Chemo(C)-, immuno(I)-, or ci-therapy using tur (or related compounds) and/or NVA (or EPV)
05/05/1998US5747475 Chitosan-derived biomaterials
05/05/1998US5747339 Vaccine production
05/05/1998US5747324 Plasmid vectors for insertion in dna for pox virus vectors, prokarotic origin and dna sequences
05/05/1998US5747318 Mitogen activated c-Fos regulating kinase, FRK
05/05/1998US5747315 DNA encoding aspartyl tRNA synthetase from Streptococcus pneumoniae
05/05/1998US5747314 Nucleotides and genetic vectors
05/05/1998US5747313 DNA encoding histidyl tRNA synthetase from Streptococcus pneumoniae
05/05/1998US5747309 Bacterial vaccines using vaccine strains of pathogenic bacteria
05/05/1998US5747307 Mason-Pfizer Monkey Retroviral packaging defective vectors
05/05/1998US5747294 Antibody formed by hybridomas produced using cells from animal immunized with borrelia burgdorferi
05/05/1998US5747287 Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
05/05/1998US5747286 Polynucleotides encoding a transcriptional response regulator of Streptococcus pneumoniae
05/05/1998US5747271 Diagnosis with peptides for detection of tumors and cancer
05/05/1998US5747269 Determination of peptide motifs on MHC molecules
05/05/1998US5747267 Method for identifying a G protein coupled glutamate receptor agonist and antagonist
05/05/1998US5747264 Measurement a phospholipase a2 polypeptide in tissue cells
05/05/1998US5747250 Probe for tumour diagnostics or tumour therapy
05/05/1998US5747242 Diagnostic kits and methods for detecting antibodies to LAV viruses
05/05/1998US5747239 Hepatitis c virus
05/05/1998US5747063 Hollow shaped envvelopes with open ends and edible substance attractive to targeted animals, agglomerants, binding for drugs
05/05/1998US5747048 Antigrowth agents agents for cancer cell
05/05/1998US5747047 Purified mite allergen
05/05/1998US5747044 Hepatitis delta diagnostics and vaccines
05/05/1998US5747040 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
05/05/1998US5747039 Recombinant herpes simplex gB-gD vaccine
05/05/1998US5747037 Monoclonal antibodies bound to epitopes secreted by hybridomas
05/05/1998US5747034 Methods and materials for the induction of T cell anergy
05/05/1998US5747031 Process for isolating immunoglobulins in whey
05/05/1998US5747028 Vaccines; genetic engineering
05/05/1998US5747024 Vaccine adjuvant comprising interleukin-15
05/05/1998US5746996 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy
05/05/1998CA2088588C Treatment of hair loss and dermatological problems
05/05/1998CA1339858C Human monoclonal antibodies specific for gp120 and gp41 and hybridomas for their production
05/05/1998CA1339857C Monoclonal antibodies to gp120 which neutraleze hiv-1
05/05/1998CA1339853C Sf-25 colon adenocarcinoma antigen, and antibodies which recognize thisantigen
04/1998
04/30/1998WO1998017826A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus
04/30/1998WO1998017820A1 Vaccines
04/30/1998WO1998017814A2 Gene expression and delivery systems and uses
04/30/1998WO1998017810A2 Multi-functional chimeric hematopoietic receptor agonists
04/30/1998WO1998017802A1 RAINBOW TROUT IL1β; ENCODING NUCLEIC ACID; MATERIALS AND METHODS
04/30/1998WO1998017799A1 Immunotherapy and improved vaccines
04/30/1998WO1998017798A1 Placental-derived prostate growth factors
04/30/1998WO1998017797A1 ANTI-ErbB2 ANTIBODIES
04/30/1998WO1998017796A2 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit
04/30/1998WO1998017795A1 Nucleic acid encoding ds-cam proteins and products related thereto
04/30/1998WO1998017793A1 Fringe proteins and notch signalling
04/30/1998WO1998017785A1 Rotavirus antigens, vaccines and diagnostic drugs for infection with rotavirus, and processes for producing the same
04/30/1998WO1998017779A1 NOVEL FabH
04/30/1998WO1998017323A1 Improved vaccines
04/30/1998WO1998017314A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
04/30/1998WO1998017313A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
04/30/1998WO1998017311A1 Additive, in particular in the form of an emulsion containing a trivalent metal cation and vaccine composition containing same
04/30/1998WO1998017310A2 Polyanionic polymers as adjuvants for mucosal immunization
04/30/1998WO1998017309A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection
04/30/1998WO1998017305A1 USE OF FasL OR FasL TRANSFECTED CD4+/FasL-/TH1-CELL LINES FOR THE TREATMENT OF TH1/TH2 DISEASES
04/30/1998WO1998017301A1 Peptides for inhibiting retroviruses
04/30/1998WO1998017300A1 Mucin-mediated immunomodulation
04/30/1998WO1998017283A1 Method of vaccinating infants against infections
04/30/1998WO1998017272A1 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
04/30/1998WO1998011225A3 A novel haemopoietin receptor and genetic sequences encoding same
04/30/1998WO1998005365A3 Compositions and methods for disinfecting contact lenses and preserving contact lens care products
04/30/1998WO1998004694A3 Secreted proteins and polynucleotides encoding them
04/30/1998DE19644501A1 GABA¶A¶-Rezeptoruntereinheit epsilon-verwandtes Protein GABA¶A¶ receptor epsilon subunit-related protein
04/30/1998CA2751712A1 Immunotherapy and improved vaccines
04/30/1998CA2745736A1 Immunotherapy and improved vaccines
04/30/1998CA2272601A1 Peptides for inhibiting retroviruses
04/30/1998CA2270154A1 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit
04/30/1998CA2269754A1 Dna vaccines for herpes simplex virus 1 and 2
04/30/1998CA2269614A1 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
04/30/1998CA2269533A1 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
04/30/1998CA2269349A1 Mucin-mediated immunomodulation
04/30/1998CA2269074A1 Immunotherapy and improved vaccines
04/30/1998CA2269034A1 Use of fasl or fasl transfected cd4+/fasl-/th1-cell lines for the treatment of th1/th2 diseases
04/30/1998CA2268949A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus
1 ... 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 ... 1823